Email updates

Keep up to date with the latest news and content from Orphanet Journal of Rare Diseases and BioMed Central.

This article is part of the supplement: 6th European Conference on Rare Diseases and Orphan Products

Open Access Meeting abstract

Developing a national plan for rare diseases in Germany through concerted action: the national action league for people with rare diseases

Véronique Héon-Klin1*, Alexandra Halbach1, Miriam Schlangen2 and Birgit Schnieders1

Author Affiliations

1 Federal Ministry of Health, Germany

2 Coordination Office of national action league for people with rare diseases – Nationales Aktionsbündnis für Menschen mit seltenen Erkrankungen (NAMSE) c/o Mukoviszidose Institut gGmbH, Germany

For all author emails, please log on.

Orphanet Journal of Rare Diseases 2012, 7(Suppl 2):A9  doi:10.1186/1750-1172-7-S2-A9


The electronic version of this article is the complete one and can be found online at: http://www.ojrd.com/content/7/S2/A9


Published:22 November 2012

© 2012 Héon-Klin et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

To improve health and well-being of people with rare diseases and to implement the Council Recommendation of the European Union on rare diseases the German Federal Ministry of Health, in cooperation with the Federal Ministry of Education and Research and the National Alliance of Patient Groups for Rare Diseases, has initiated a national action league for people with rare diseases - Nationales Aktionsbündnis für Menschen mit Seltenen Erkrankungen (NAMSE). NAMSE brings together all key bodies and organisations of the German health care system (27 in total) to enable concerted action based on the adoption of a joint declaration. In four working groups on “Information, Diagnosis, Care/Centres/Networks and Research” of NAMSE recommendations are being developed.

Results

The process of identifying and later labelling national centres of expertise and their participation in European Reference Networks is of central importance. Three types of centres have already been defined on the basis of specific criteria (Figure 1). These can be differentiated in disease/disease-group specific medical care functions or structures and non-disease specific activities (important for all rare diseases). To guide patients and health care professionals through the health care system a common, quality assured information platform, pooling the existing information services, is discussed.

NAMSE pursues a patient-centred approach respecting the patients and their concerns. Therefore seamless care pathways are a recurrent theme throughout the planned measures. They are considered to accelerate the diagnosis and are of central importance for patient without diagnosis.

Conclusions

Each working group of NAMSE has developed a set of advices. For all special indicators with targets and a timeline are being developed to evaluate their effectiveness after their implementation. Therefore an evaluation board comments all indicators proposed for the different advices. All advices have to be prioritised based on their probability of implementation by a consensus conference. The draft of German National Action Plan will be assigned to the Federal Ministry of Health in 2013.

Acknowledgement

BMBF: Bundesministerium für Bildung und Forschung/Federal Ministry of Education and Research ACHSE e.V.: Allianz Chronischer Seltener Erkrankungen/Alliance for Chronic Rare Diseases.